ag-1296 has been researched along with Scleroderma, Systemic in 1 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baroni, SS | 1 |
| Santillo, M | 1 |
| Bevilacqua, F | 1 |
| Luchetti, M | 1 |
| Spadoni, T | 1 |
| Mancini, M | 1 |
| Fraticelli, P | 1 |
| Sambo, P | 1 |
| Funaro, A | 1 |
| Kazlauskas, A | 1 |
| Avvedimento, EV | 1 |
| Gabrielli, A | 1 |
1 other study available for ag-1296 and Scleroderma, Systemic
| Article | Year |
|---|---|
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
Topics: Adult; Aged; Animals; Autoantibodies; Autoimmune Diseases; Biological Assay; Case-Control Studies; C | 2006 |